Stock Price
81.38
Daily Change
0.04 0.05%
Monthly
2.95%
Yearly
4.33%
Q2 Forecast
79.74

Edwards Lifesciences reported $0.78 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 0.78 0.73 0.64 Apr/23
FY2025Q4 Dec/2025 0.58 0.62 0.59 Feb/10
FY2025Q3 Sep/2025 0.67 0.59 0.67 Oct/30
FY2025Q2 Jun/2025 0.67 0.62 0.70 Jul/24
FY2025Q1 Mar/2025 0.64 0.59 0.66 Apr/23




Eps Change Date
Abbott USD 1.15 0.35 Mar/2026
Artivion USD -0.02 0.2 Dec/2025
AtriCure USD 0 0.06 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Becton, Dickinson and Co. USD 2.9 0.01 Mar/2026
Boston Scientific USD 0.8 0 Mar/2026
Cooper Companies USD 0.66 0.26 Dec/2025
Dexcom USD 0.56 0.12 Mar/2026
Edwards Lifesciences USD 0.78 0.2 Mar/2026
Globus Medical USD 1.12 0.16 Mar/2026
ICU Medical USD 1.97 0.06 Mar/2026
Inogen USD -0.25 0.01 Sep/2024
Insulet USD 1.42 0.02 Mar/2026
Integra LifeSciences USD 0.54 0.29 Mar/2026
Intuitive Surgical USD 2.5 0.03 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Masimo USD 1.09 1.27 Mar/2026
Medtronic USD 1.36 0.29 Jan/2026
Merit Medical Systems USD 0.86 0.18 Mar/2026
Stryker USD 2.6 1.87 Mar/2026
Tandem Diabetes Care USD -0.3 0.29 Mar/2026
Teleflex USD 1.39 0.54 Mar/2026
Zimmer Biomet Holdings USD 2.09 0.33 Mar/2026